Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of ... More | Chart | Post
Full Profile of ABEO (Abeona Therapeutics Inc.) : Nasdaq
Market Cap: 871.34M | Industry: Health Care/Life Sciences
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy and plasma-based products for severe and life threatening rare diseases. It includes gene therapies for sanfilippo syndrome, recessive dystrophic...
$ABEO Abeona Therapeutics: FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to ABO-102, the Company's AAV-mediated gene therapy for the treatment of Sanfilippo syndrome Type A.
$ABEO Abeona Therapeutics: EMA Committee for Orphan Medicinal Products has granted Orphan Drug Designation (EMA/OD/013/18) for Abeona's gene therapy program ABO-202 for the treatment of subjects with neuronal ceroid lipofuscinosis.
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy and plasma-based products for severe and life threatening rare diseases. It includes gene therapies for sanfilippo syndrome, recessive dystrophic...